Summit Therapeutics Inc (NAS:SMMT)
$ 21.74 0.33 (1.54%) Market Cap: 16.03 Bil Enterprise Value: 15.35 Bil PE Ratio: 0 PB Ratio: 36.85 GF Score: 30/100